BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  908 Devices Advances MX908 Handheld Device Capabilities

  908 Devices Inc. today announced updates to its MX908 handheld mass spec device, adding new capabilities to streamline workflows and improve field safety for first responders.

  May 9, 2022

   · 

  4 min read
• Business

  Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business Update

  Precision BioSciences, Inc. today announced financial results for the first quarter ended March 31, 2022 and provided a business update.

  May 9, 2022

   · 

  15 min read
• Business

  ADC Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

  ADC Therapeutics SA today reported financial results for the first quarter ended March 31, 2022 and provided business updates.

  May 9, 2022

   · 

  18 min read
• Business

  Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2022

  Surface Oncology reported financial results and corporate highlights for the first quarter of 2022 as well as upcoming anticipated corporate milestones.

  May 9, 2022

   · 

  10 min read
• Drug Development

  Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

  Resverlogix Corp. today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s request for a Type C meeting to review the clinical trial protocol for its Phase 3 study of apabetalone in high-risk COVID-19 outpatients.

  May 9, 2022

   · 

  7 min read
• Biomind Labs to Argument Which Psychedelic Medicines Will Lead the Industry Into Its Next Phase of Evolution at The National Gallery in London

  Biomind Labs Inc. is pleased to announce that its CEO Alejandro Antalich will be debating in the “PSYCH Symposium: London 2022.

  May 9, 2022

   · 

  6 min read
• Business

  Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results

  Verrica Pharmaceuticals Inc. today announced financial results for the first quarter ended March 31, 2022.

  May 9, 2022

   · 

  10 min read
• Business

  Syros to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

  Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Monday, May 16, 2022 to report its first quarter 2022 financial results and provide a corporate update.

  May 9, 2022

   · 

  1 min read
• Business

  Celcuity Inc. Schedules Release of First Quarter 2022 Financial Results and Webcast/Conference Call

  Celcuity Inc. today announced that it will release its financial results for the first quarter 2022 after the stock market close on Monday, May 16, 2022.

  May 9, 2022

   · 

  1 min read
• OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting

  OBiO Technology today announced that research on novel manufacturing technologies via its OVersatile™ platform will be presented at the American Society of Cell & Gene Therapy (ASCGT) 25th Annual meeting on May 16-19, 2022 in Washington, D.C.

  May 9, 2022

   · 

  2 min read